Multiple vertebral fractures after suspension of denosumab. A series of 56 cases-Reference-Cited by-同舟云学术

Multiple vertebral fractures after suspension of denosumab. A series of 56 cases

Published:2021-06-30 Issue:10 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Sosa‐Henríquez Manuel¹^ORCID,Torregrosa Oscar²,Déniz Alejandro³,Saavedra Pedro⁴,Ortego Norberto⁵,Turrión Ana⁶,Pérez Castrillón José Luis⁷,Díaz‐Curiel Manuel⁸,Gómez‐Alonso Carlos⁹,Martínez Guillermo¹⁰,Antonio Blázquez José¹¹,Olmos‐Martínez José Manuel¹²,Etxebarria Íñigo¹³,Caeiro José Ramón¹⁴,Mora‐Peña Damián¹⁵

Affiliation:

1. University of Las Palmas de Gran CanariaInvestigation Group on Osteoporosis and Bone Mineral MetabolismHospital University InsularLas Palmas de Gran Canaria Canary Islands Spain

2. Internal Medicine Service Hospital General University Elche Elche Alicante Spain

3. Endocrinology Section Hospital University Insular Las Palmas de Gran Canaria Spain

4. Mathematics Department University of Las Palmas de Gran Canaria Las Palmas de Gran Canaria Spain

5. Internal Medicine Hospital University San Cecilio Granada Spain

6. Rheumatology Service Hospital University Salamanca Salamanca Spain

7. Internal Medicine Hospital University Río Hortega Valladolid Spain

8. Internal Medicine Service Hospital University Fundación Jiménez Díaz Madrid Spain

9. Internal Medicine Service Hospital University Central Asturias Oviedo Spain

10. Endocrinology Service Hospital University 12 de Octubre Madrid Spain

11. Internal Medicine Service Hospital General University Albacete Albacete Spain

12. Internal Medicine Service Hospital Universitario Marqués de Valdecilla Santander Spain

13. Orthopaedic Surgery Hospital Alto Deba Guipúzcoa Spain

14. Orthopaedic Surgery Department University Hospital of Santiago de Compostela La Coruña Spain

15. Internal Medicine Service Hospital Virgen de la Luz Cuenca Spain

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.14550

Reference36 articles.

1. Denosumab for bone diseases: translating bone biology into targeted therapy

2. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

3. Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years

4. The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT)

5. Bone Mineral Density Changes After 1 Year of Denosumab Discontinuation in Postmenopausal Women with Long-Term Denosumab Treatment for Osteoporosis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. On-time denosumab dosing recovered rapidly during the COVID-19 pandemic, yet remains suboptimal;JBMR Plus;2024-03-28

2. Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications;Bone Reports;2024-03

3. Trabecular bone deterioration in a postmenopausal female suffering multiple spontaneous vertebral fractures due to a delayed denosumab injection – A post-treatment re-initiation bone biopsy-based case study;Bone Reports;2023-12

4. Maintenance of bone resorption markers in the low premenopausal range during the year following denosumab discontinuation is associated to bone density preservation. The ReoLaus study;Bone;2023-07

5. Denosumab as a Pharmacological Countermeasure Against Osteopenia in Long Duration Spaceflight;Aerospace Medicine and Human Performance;2023-05-01